NEOVANCE

Serial Number 98854556
680

Registration Progress

Application Filed
Nov 14, 2024
Under Examination
Approved for Publication
Published for Opposition
Registered

Attorney Assistance

Examiner's Amendment Completed
Due: Jul 31, 2025 7 days

Trademark Image

NEOVANCE

Basic Information

Serial Number
98854556
Filing Date
November 14, 2024
Drawing Code
3

Status Summary

Current Status
Active
Status Code
680
Status Date
Jul 16, 2025
Application
Pending
Classes
044

Rights Holder

Neovance L.P.

13
Address
8045 Arco Corporate Drive, Suite 250
Raleigh, NC 27617

Ownership History

Neovance L.P.

Original Applicant
13
Raleigh, NC

Legal Representation

Attorney
Tore T. DeBella

USPTO Deadlines

Next Deadline
7 days remaining
Examiner's Amendment Completed
Due Date
July 31, 2025
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

12 events
Date Code Type Description Documents
Jul 16, 2025 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jul 16, 2025 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Jul 16, 2025 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Jul 16, 2025 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Jul 16, 2025 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
May 31, 2025 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
May 31, 2025 GNRT F NON-FINAL ACTION E-MAILED Loading...
May 31, 2025 CNRT R NON-FINAL ACTION WRITTEN Loading...
May 10, 2025 DOCK D ASSIGNED TO EXAMINER Loading...
May 7, 2025 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
May 7, 2025 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Nov 14, 2024 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 044
Preparation of prescriptions in pharmacies; providing patient access and assistance programs providing financial assistance to low-income patients for medical products; providing an online computer database featuring medical information in the field of patient management and outcomes; providing a website featuring medical information in the field of patient management and outcomes; medical and pharmaceutical consultation; providing information on healthcare; providing information to patients about medication access; providing patient and physician adherence, self-management, and compliance outreach programs; charitable services, namely, patient assistance program support services for providing prescription pharmaceuticals at reduced or no cost for eligible patients

Additional Information

Design Mark
The mark consists of the letters "neovance" appearing horizontally in stylized font, with the letters "neo" appearing atop a parallelogram-shaped background and the letters "vance" appearing above a horizontal line.
Color Claim
Color is not claimed as a feature of the mark.

Classification

International Classes
044